DNAnexus
DNAnexus is a leading enterprise platform provider dedicated to advancing scientific discovery and precision health through secure, scalable, and compliant cloud-based solutions. The company focuses on enabling biomedical organizations, medical centers, and biopharma companies to accelerate research, optimize analysis pipelines, and facilitate collaboration across multimodal health data, including genomics, multiomics, and clinical data. With a mission to make precision health a reality for all, DNAnexus offers a comprehensive suite of tools, services, and trusted research environments to support innovation, reduce operational costs, and drive breakthroughs in human health.
Industries
Nr. of Employees
medium (51-250)
Products
Multi-omics data science and exploration platform
Cloud platform for ingesting, organizing, analyzing and visualizing multimodal omics and clinical data with embedded notebooks, cohort building, and analytic applications for exploratory research.
NGS data analysis and production platform
Cloud-native environment optimized for next-generation sequencing secondary analysis, pipeline automation, high-throughput production workloads, and operational monitoring.
Configurable collaborative portals and TRE deployments
White-labeled, customizable portals and trusted research environment deployments that deliver analysis-ready data access with role-based controls and configurable data export/dispensal rules.
Regulatory and quality support for clinical and manufacturing workflows
Services and platform configurations to support GxP-aligned deployments, maintain compliant environments in the cloud, and retain audit-ready records for regulated workflows.
Multi-omics data science and exploration platform
Cloud platform for ingesting, organizing, analyzing and visualizing multimodal omics and clinical data with embedded notebooks, cohort building, and analytic applications for exploratory research.
NGS data analysis and production platform
Cloud-native environment optimized for next-generation sequencing secondary analysis, pipeline automation, high-throughput production workloads, and operational monitoring.
Configurable collaborative portals and TRE deployments
White-labeled, customizable portals and trusted research environment deployments that deliver analysis-ready data access with role-based controls and configurable data export/dispensal rules.
Regulatory and quality support for clinical and manufacturing workflows
Services and platform configurations to support GxP-aligned deployments, maintain compliant environments in the cloud, and retain audit-ready records for regulated workflows.
Services
Configuration of platform environments, custom workflow development, portal customization, regulatory and GxP support, genome assembly assistance, training, onboarding, and scientific consulting.
Ongoing managed operation of cloud-based data management and analysis environments, including platform maintenance, security patching, support, and operational monitoring.
Configuration of platform environments, custom workflow development, portal customization, regulatory and GxP support, genome assembly assistance, training, onboarding, and scientific consulting.
Ongoing managed operation of cloud-based data management and analysis environments, including platform maintenance, security patching, support, and operational monitoring.
Expertise Areas
- Bioinformatics workflow development and deployment
- Multiomics data integration and management
- Population-scale genomics and cohort analytics
- Clinical and diagnostics informatics (secondary analysis pipelines)
Key Technologies
- Next-generation sequencing (NGS) secondary analysis
- Whole-genome sequencing (WGS) analytics
- Workflow languages (Nextflow, WDL)
- Containerization and containerized tools
News & Updates
DNAnexus will be on-site in Marco Island, FL for the AGBT General Meeting Feb. 23-26, 2025, and we'd love to meet with you and discuss how we can help accelerate analysis of your precision health data.
DNAnexus offers a platform to manage, analyze, and collaborate on multimodal data to unlock insights that improve patient care.
DNAnexus was recognized as a finalist for the 2024 Innovation Awards.
DNAnexus was ranked #4 on Fast Company's list of most innovative biotech companies in 2023.
DNAnexus was named the 2023 Company of the Year by Frost & Sullivan for its contributions to precision medicine informatics.
DNAnexus will be on-site in Marco Island, FL for the AGBT General Meeting Feb. 23-26, 2025, and we'd love to meet with you and discuss how we can help accelerate analysis of your precision health data.
DNAnexus offers a platform to manage, analyze, and collaborate on multimodal data to unlock insights that improve patient care.
DNAnexus was recognized as a finalist for the 2024 Innovation Awards.
DNAnexus was ranked #4 on Fast Company's list of most innovative biotech companies in 2023.
DNAnexus was named the 2023 Company of the Year by Frost & Sullivan for its contributions to precision medicine informatics.